Chronic 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Treatment Induces Phenotypic Changes in Skeletal Muscle, but Does Not Improve Disease Outcomes in the R6/2 Mouse Model of Huntington’s Disease
Huntington’s disease (HD) is an autosomal dominant neurodegenerative genetic disorder characterized by motor, cognitive, and psychiatric symptoms. It is well established that regular physical activity supports brain health, benefiting cognitive function, mental health as well as brain structure and...
Main Authors: | Marie-France Paré, Bernard J. Jasmin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-09-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fneur.2017.00516/full |
Similar Items
-
Alteration of CYP3A1 mRNA Level in Primary Rat Hepatocytes in Response to AMPK Activator AICAR
by: Bang-Sub Lee, et al.
Published: (2019-03-01) -
Significance of 5’AMP-activated protein kinase in metabolomic regulation by skeletal muscle contraction
by: Licht Miyamoto
Published: (2015-03-01) -
The effect of 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) on fatty acid oxidation in hepatocytes isolated from neonatal piglets
by: Xi Lin, et al.
Published: (2012-10-01) -
Aspirin and 5-Aminoimidazole-4-carboxamide Riboside Attenuate Bovine Ephemeral Fever Virus Replication by Inhibiting BEFV-Induced Autophagy
by: Hsu-Hung Tseng, et al.
Published: (2020-11-01) -
Chronic AMP-kinase activation with AICAR reduces adiposity by remodeling adipocyte metabolism and increasing leptin sensitivity
by: Mandeep P. Gaidhu, et al.
Published: (2011-09-01)